Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy
Glioblastoma (GBM) is the most common and devastating primary cancer of the central nervous system in adults. High grade gliomas are able to modify and respond to the brain microenvironment. When GBM tumors infiltrate the Subventricular zone (SVZ) they have a more aggressive clinical presentation th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.624145/full |
id |
doaj-aebdd3f19de74e6f81f92c2a469975ac |
---|---|
record_format |
Article |
spelling |
doaj-aebdd3f19de74e6f81f92c2a469975ac2021-03-04T05:16:57ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.624145624145Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma MalignancyAnna Carrano0Natanael Zarco1Jordan Phillipps2Montserrat Lara-Velazquez3Paola Suarez-Meade4Emily S. Norton5Emily S. Norton6Emily S. Norton7Kaisorn L. Chaichana8Alfredo Quiñones-Hinojosa9Yan W. Asmann10Hugo Guerrero-Cázares11Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesNeuroscience Graduate Program, Mayo Clinic Graduate School of Biochemical Sciences, Mayo Clinic, Jacksonville, FL, United StatesRegenerative Sciences Training Program, Center for Regenerative Medicine, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesGlioblastoma (GBM) is the most common and devastating primary cancer of the central nervous system in adults. High grade gliomas are able to modify and respond to the brain microenvironment. When GBM tumors infiltrate the Subventricular zone (SVZ) they have a more aggressive clinical presentation than SVZ-distal tumors. We suggest that cerebrospinal fluid (CSF) contact contributes to enhance GBM malignant characteristics in these tumors. We evaluated the impact of human CSF on GBM, performing a transcriptome analysis on human primary GBM cells exposed to CSF to measure changes in gene expression profile and their clinical relevance on disease outcome. In addition we evaluated the proliferation and migration changes of CSF-exposed GBM cells in vitro and in vivo. CSF induced transcriptomic changes in pathways promoting cell malignancy, such as apoptosis, survival, cell motility, angiogenesis, inflammation, and glucose metabolism. A genetic signature extracted from the identified transcriptional changes in response to CSF proved to be predictive of GBM patient survival using the TCGA database. Furthermore, CSF induced an increase in viability, proliferation rate, and self-renewing capacity, as well as the migratory capabilities of GBM cells in vitro. In vivo, GBM cells co-injected with human CSF generated larger and more proliferative tumors compared to controls. Taken together, these results provide direct evidence that CSF is a key player in determining tumor growth and invasion through the activation of complex gene expression patterns characteristic of a malignant phenotype. These findings have diagnostic and therapeutic implications for GBM patients. The changes induced by CSF contact might play a role in the increased malignancy of SVZ-proximal GBM.https://www.frontiersin.org/articles/10.3389/fonc.2021.624145/fullglioblastomacerebrospinal fluidcancer progressiontumor stem cellsbrain tumorsubventricular zone |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Carrano Natanael Zarco Jordan Phillipps Montserrat Lara-Velazquez Paola Suarez-Meade Emily S. Norton Emily S. Norton Emily S. Norton Kaisorn L. Chaichana Alfredo Quiñones-Hinojosa Yan W. Asmann Hugo Guerrero-Cázares |
spellingShingle |
Anna Carrano Natanael Zarco Jordan Phillipps Montserrat Lara-Velazquez Paola Suarez-Meade Emily S. Norton Emily S. Norton Emily S. Norton Kaisorn L. Chaichana Alfredo Quiñones-Hinojosa Yan W. Asmann Hugo Guerrero-Cázares Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy Frontiers in Oncology glioblastoma cerebrospinal fluid cancer progression tumor stem cells brain tumor subventricular zone |
author_facet |
Anna Carrano Natanael Zarco Jordan Phillipps Montserrat Lara-Velazquez Paola Suarez-Meade Emily S. Norton Emily S. Norton Emily S. Norton Kaisorn L. Chaichana Alfredo Quiñones-Hinojosa Yan W. Asmann Hugo Guerrero-Cázares |
author_sort |
Anna Carrano |
title |
Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy |
title_short |
Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy |
title_full |
Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy |
title_fullStr |
Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy |
title_full_unstemmed |
Human Cerebrospinal Fluid Modulates Pathways Promoting Glioblastoma Malignancy |
title_sort |
human cerebrospinal fluid modulates pathways promoting glioblastoma malignancy |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-03-01 |
description |
Glioblastoma (GBM) is the most common and devastating primary cancer of the central nervous system in adults. High grade gliomas are able to modify and respond to the brain microenvironment. When GBM tumors infiltrate the Subventricular zone (SVZ) they have a more aggressive clinical presentation than SVZ-distal tumors. We suggest that cerebrospinal fluid (CSF) contact contributes to enhance GBM malignant characteristics in these tumors. We evaluated the impact of human CSF on GBM, performing a transcriptome analysis on human primary GBM cells exposed to CSF to measure changes in gene expression profile and their clinical relevance on disease outcome. In addition we evaluated the proliferation and migration changes of CSF-exposed GBM cells in vitro and in vivo. CSF induced transcriptomic changes in pathways promoting cell malignancy, such as apoptosis, survival, cell motility, angiogenesis, inflammation, and glucose metabolism. A genetic signature extracted from the identified transcriptional changes in response to CSF proved to be predictive of GBM patient survival using the TCGA database. Furthermore, CSF induced an increase in viability, proliferation rate, and self-renewing capacity, as well as the migratory capabilities of GBM cells in vitro. In vivo, GBM cells co-injected with human CSF generated larger and more proliferative tumors compared to controls. Taken together, these results provide direct evidence that CSF is a key player in determining tumor growth and invasion through the activation of complex gene expression patterns characteristic of a malignant phenotype. These findings have diagnostic and therapeutic implications for GBM patients. The changes induced by CSF contact might play a role in the increased malignancy of SVZ-proximal GBM. |
topic |
glioblastoma cerebrospinal fluid cancer progression tumor stem cells brain tumor subventricular zone |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.624145/full |
work_keys_str_mv |
AT annacarrano humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT natanaelzarco humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT jordanphillipps humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT montserratlaravelazquez humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT paolasuarezmeade humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT emilysnorton humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT emilysnorton humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT emilysnorton humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT kaisornlchaichana humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT alfredoquinoneshinojosa humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT yanwasmann humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy AT hugoguerrerocazares humancerebrospinalfluidmodulatespathwayspromotingglioblastomamalignancy |
_version_ |
1724232273469898752 |